Reaction

Anaphylactoid Reaction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,043 reports · 91 co-occurring drugs

As of the last recalculation, Anaphylactoid Reaction appears in 4,043 FAERS reports alongside 91 co-occurring drug terms. The strongest observed disproportionality signal is IRON SUCROSE (PRR 26.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Iron Sucrose	48	26.2	26.3
Acetylcysteine	42	23.2	23.3
Diphenhydramine Hcl	39	18.2	18.2
Iohexol	29	18.1	18.2
Rocuronium Bromide	38	16.8	16.8
Propofol	106	15.3	15.4
Cimetidine	24	12.9	12.9
Cefazolin Sodium	29	12.5	12.5
Miconazole Nitrate	21	12.4	12.5
Sevoflurane	17	10.6	10.6
Cefazolin	18	10.2	10.2
Atropine	16	10.0	10.0
Atropine Sulfate	20	9.6	9.6
Hydrocortisone Sodium Succinate	17	9.3	9.4
Heparin Sodium	23	8.7	8.7
Aprepitant	28	7.9	7.9
Omalizumab	124	7.7	7.7
Fosaprepitant Dimeglumine	20	7.5	7.5
Granisetron Hydrochloride	15	7.4	7.4
Oxaliplatin	101	7.2	7.2
Midazolam Hydrochloride	36	6.9	6.9
Midazolam	31	6.4	6.4
Panitumumab	19	6.3	6.3
Tranexamic Acid	10	5.8	5.8
Dextrose Monohydrate	15	5.8	5.8
Pegvaliase-Pqpz	9	5.7	5.7
Sodium Chloride Tablet	78	5.5	5.5
Sodium Chloride Tablets	78	5.5	5.5
Paclitaxel (Aibumin-Bound)	86	5.5	5.5
Sodium Chloride	82	5.4	5.4
Methylprednisolone Sodium Succinate	48	5.4	5.4
Cetuximab	31	5.1	5.1
Dexamethasone Sodium Phosphate	10	5.1	5.1
Brentuximab Vedotin	10	5.0	5.0
Agalsidase Beta	9	5.0	5.0
Leucovorin Calcium	18	4.9	4.9
Irinotecan Hydrochloride	12	4.8	4.8
Fluorouracil Cream, 0.5%	68	4.7	4.7
Paclitaxel	87	4.6	4.6
Fluorouracil	68	4.6	4.6
Alteplase	13	4.5	4.5
Granisetron	9	4.4	4.4
Lidocaine Hydrochloride	51	4.4	4.4
Obinutuzumab	14	4.4	4.4
Dextrose	11	4.3	4.3
Lidocaine Hydrochloride And Epinephrine Bitartrate	44	4.3	4.3
Desloratadine	8	3.8	3.8
Colchicine	19	3.7	3.7
Vancomycin Hydrochloride	47	3.7	3.7
Felodipine Extended-Release Tablets	8	3.6	3.6
Felodipine	8	3.6	3.6
Fentanyl Citrate	12	3.5	3.5
Doxazosin Mesylate	24	3.4	3.4
Infliximab	140	3.4	3.4
Fentanyl	64	3.4	3.4
Trastuzumab	43	3.2	3.3
Ondansetron	68	3.2	3.2
Ondansetron Tablets	68	3.2	3.2
Vancomycin	36	3.2	3.2
Norepinephrine Bitartrate	9	3.2	3.2
Baricitinib	6	3.2	3.2
Anti-Thymocyte Globulin (Rabbit)	5	3.2	3.2
Oseltamivir Phosphate	15	3.2	3.2
Pemetrexed Disodium	23	3.1	3.1
Mesna Injection	5	3.1	3.1
Mesna	5	3.1	3.1
Pertuzumab	16	3.0	3.0
Carboplatin	72	3.0	3.0
Norepinephrine	6	2.9	2.9
Rifampin	8	2.8	2.8
Bupivacaine	5	2.8	2.8
Oseltamivir	4	2.6	2.6
Asfotase Alfa	5	2.6	2.6
Canakinumab	5	2.4	2.4
Bevacizumab	56	2.3	2.3
Bendamustine Hcl	7	2.3	2.3
Pyrazinamide	4	2.2	2.2
Pegaspargase	5	2.1	2.1
Lanreotide Acetate	3	2.0	2.0
Tofacitinib Citrate	5	2.0	2.0
Gemcitabine	15	2.0	2.0
Pemetrexed	8	1.9	1.9
Apalutamide	4	1.8	1.8
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	3	1.7	1.7
Eptinezumab-Jjmr	3	1.7	1.7
Glatiramer Acetate	18	1.6	1.6
Methoxy Polyethylene Glycol-Epoetin Beta	3	1.4	1.4
Sevelamer Carbonate	3	1.3	1.3
Benralizumab	5	1.3	1.3
Emicizumab	3	1.3	1.3
Ranitidine Hydrochloride	12	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.